歡迎光臨源葉生物,登錄 | 注冊 |
當前位置: 首頁 > 小分子抑制劑 > DNADamage/DNARepair > PIK-90

瀏覽歷史

S80890

PIK-90

源葉(MedMol) 99%
  • 英文名:
  • PIK-90
  • 別名:
  • CAS號:
  • 677338-12-4
  • 分子式:
  • C18H17N5O3
  • 分子量:
  • 351.36
  • 核磁/質(zhì)譜:
品牌貨號產(chǎn)品規(guī)格價格(RMB) 庫存(上海) 北京 武漢 南京 數(shù)量計量單位 加入購物車...
源葉(MedMol) S80890-2mg 99% ¥270.00元 5 - - - EA 加入購物車
源葉(MedMol) S80890-5mg 99% ¥400.00元 4 - - - EA 加入購物車
源葉(MedMol) S80890-10mg 99% ¥650.00元 6 - - - EA 加入購物車
源葉(MedMol) S80890-25mg 99% ¥1250.00元 3 - - - EA 加入購物車
源葉(MedMol) S80890-50mg 99% ¥2000.00元 預計交期:2-3天 - - - EA 加入購物車
源葉(MedMol) S80890-100mg 99% ¥3300.00元 預計交期:2-3天 - - - EA 加入購物車
大包裝詢價

提交您的電話號碼并同意《個人信息授權(quán)與保護申明》,到貨后將短信提示。
提交

產(chǎn)品介紹

參考文獻

質(zhì)檢證書(COA)

摩爾濃度計算器

相關產(chǎn)品

  • 提示:詳情請下載說明書。
  • 產(chǎn)品描述: PIK-90 is a DNA-PK and PI3K inhibitor, which inhibits p110α, p110γ and DNA-PK with IC50s of 11, 18 and 13 nM, respectively.
  • 靶點: p110α:11 nM (IC50);p110γ:18 nM (IC50);p110δ:58 nM (IC50);p110β:350 nM (IC50);hsVPS34:830 nM (IC50);PI3KC2β:64 nM (IC50);PI3KC2α:47 nM (IC50);DNA-PK:13 nM (IC50);ATM:610 nM (IC50);PI4KIIIα:830 nM (IC50);PI4KIIIβ:3.1 μM (IC50);mTORC1:1.05 μM (IC50);ATR:15 μM (IC50);DNA-PK;PI3K
  • 體內(nèi)研究:
    To test the efficacy of Roscovitine and PIK-90 in vivo, GBM43 cells are implanted s.c. into nude mice. Mice with established tumors are randomized into four treatment groups: vehicle (PBS:H2O), Roscovitine, PIK-90, or PIK-90 plus Roscovitine. After 12 d of treatment, both Roscovitine and PIK-90 show clear single-agent efficacy, with tumor size in mice treated with Roscovitine and PIK-90 in combination significantly smaller than either vehicle or monotherapy-treated controls. Roscovitine is less effective than PIK-90 in blocking proliferation (levels of Ki-67), whereas combination therapy shows essentially additive antiproliferative effects
  • 參考文獻:
    1. Knight ZA, et al. A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling. Cell. 2006 May 19;125(4):733-47. 2. Niedermeier M, et al. Isoform-selective phosphoinositide 3'-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell-mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approach. Blood. 2009 May 28;113(22):5549-57. 3. Cheng CK, et al. Dual blockade of lipid and cyclin-dependent kinases induces synthetic lethality in malignant glioma. Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12722-7.
  • 溶解性: DMSO  :  6.67  mg/mL  (18.98  mM;  ultrasonic  and  adjust  pH  to  2  with  HCl)
  • 保存條件: -20℃
  • 配置溶液濃度參考:
    1mg 5mg 10mg
    1 mM 2.846 ml 14.23 ml 28.461 ml
    5 mM 0.569 ml 2.846 ml 5.692 ml
    10 mM 0.285 ml 1.423 ml 2.846 ml
    50 mM 0.057 ml 0.285 ml 0.569 ml
  • 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。
輸入產(chǎn)品批號:

本計算器可幫助您計算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關系,公式為:


質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)


  • =
    *
    *


源葉所有產(chǎn)品僅用作科學研究,銷售產(chǎn)品行為均適用于我司網(wǎng)上所列通用銷售條款。